2. Describe the impact of ACPE standards and guidelines related to rotation syllabi development.
3. Discuss best practices for incorporating students into your daily practice.
4. Identify new learning activities to incorporate into your rotation syllabus.
5. Create/Update rotation-specific syllabi to meet accreditation standards.
- Participants are to enter through Gate 3
- Pull a ticket to enter the parking area
- Drive through the Faculty/Staff parking area (NO PARKING FOR CONFERENCE)
- Follow the sign that leads to the “Pay Area” (which will be located on the first ramp)
- Participants will be provided with a “Pass” that will be used to exit the garage.
Date: Mar 8, 2017 09:00 AM - 04:00 PM
Fee
CE Hours
CE Units
Registration closes on Mar 01, 2017 11:55 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Registration closes on Mar 01, 2017
at 11:55 PM
Registration Closed
2. Describe the impact of ACPE standards and guidelines related to rotation syllabi development.
3. Discuss best practices for incorporating students into your daily practice.
4. Identify new learning activities to incorporate into your rotation syllabus.
5. Create/Update rotation-specific syllabi to meet accreditation standards.
Speaker(s)/Author(s)
Cathy Worrall, PharmD, FAPhA, BCPS
|
|
Jennifer Baker, PharmD
|
|
Phillip Hall, PharmD
|
|
Stephen Cutler, PhD
|
Activity Number
0062-0000-17-056-L04-PCE Hours
Registration Closed
1. Discuss the FDA warnings and label changes that relate to medication safety and how this information should be applied in the selection and monitoring of evidence-based pharmacotherapy to achieve better patient related outcomes.
2. Describe the current information concerning newly FDA approved medications (pharmacology,pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring and cost) in the selection of evidence-based pharmacotherapy.
3. Compare and contract these selected newer agents to the existing therapies and be able to recommend an appropriate medication regimen for a specific patient.
Speaker(s)/Author(s)
C. Wayne Weart, PharmD, FASHP, FAPhA
|